Bank Of America Corp Akero Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 159,558 shares of AKRO stock, worth $4.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

159,558

Previous 262,230 39.15%

Holding current value

$4.97 Million

Previous $6.15 Million 25.59%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$21.45 - $29.34 $2.2 Million - $3.01 Million	-102,672 Reduced 39.15%	159,558 $4.58 Million
Q2 2024 Aug 14, 2024	SELL	$18.31 - $24.62 $3 Million - $4.03 Million	-163,641 Reduced 38.43%	262,230 $6.15 Million
Q1 2024 May 15, 2024	SELL	$17.76 - $31.18 $1.13 Million - $1.99 Million	-63,770 Reduced 13.02%	425,871 $10.8 Million
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $3.88 Million - $17.1 Million	340,722 Added 228.8%	489,641 $11.4 Million
Q2 2023 Aug 14, 2023	SELL	$36.89 - $56.88 $3.04 Million - $4.69 Million	-82,502 Reduced 35.65%	148,919 $6.95 Million
Q1 2023 May 12, 2023	BUY	$37.27 - $50.24 $1.08 Million - $1.46 Million	29,032 Added 14.34%	231,421 $8.85 Million
Q4 2022 Feb 10, 2023	BUY	$33.44 - $54.8 $4.42 Million - $7.24 Million	132,069 Added 187.81%	202,389 $11.1 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $323,196 - $1.08 Million	31,842 Added 82.75%	70,320 $2.39 Million
Q2 2022 Aug 12, 2022	SELL	$8.0 - $15.01 $190,104 - $356,682	-23,763 Reduced 38.18%	38,478 $363,000
Q1 2022 May 16, 2022	BUY	$12.97 - $22.26 $291,202 - $499,781	22,452 Added 56.43%	62,241 $883,000
Q4 2021 Feb 08, 2022	SELL	$19.87 - $26.24 $283,346 - $374,182	-14,260 Reduced 26.38%	39,789 $842,000
Q3 2021 Nov 15, 2021	BUY	$18.65 - $25.46 $844,826 - $1.15 Million	45,299 Added 517.7%	54,049 $1.21 Million
Q2 2021 Sep 13, 2021	BUY	$24.81 - $32.35 $217,087 - $283,062	8,750 New	8,750 $217,000

Others Institutions Holding AKRO

# of Institutions

190

Shares Held

73.8M

Call Options Held

241K

Put Options Held

647K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.45B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Akero Therapeutics, Inc. Transaction History